Lusefi 2.5mg Tab

Manufacturer
Taisho Pharmaceutical Co., Ltd.

Registraction Number     
MAL18091001AZ


 

Content

• Active Ingredient: Each tablet contains 2.5 mg of luseogliflozin hydrate, equivalent to 2.5 mg of luseogliflozin.
• Excipients: Includes lactose hydrate, microcrystalline cellulose, sodium starch glycolate, hydroxypropylcellulose, magnesium stearate, hypromellose, titanium oxide, macrogol 400, carnauba wax, and light anhydrous silicic acid.
• Appearance: White, film-coated tablets approximately 7.1 mm in diameter and 3.2 mm in thickness.

Indications

• Monotherapy: For adults with type 2 diabetes mellitus whose blood glucose is inadequately controlled by diet and exercise alone, and for whom metformin is considered inappropriate due to intolerance.
• Add-on Combination Therapy: In combination with other glucose-lowering medications, including insulin preparations, in adult patients with type 2 diabetes mellitus to improve glycemic control when diet and exercise plus monotherapy do not provide adequate control.

Instructions

• Dosage: Take 1 tablet (2.5 mg) once daily, either before or after breakfast. If the effect is insufficient, the dose may be increased to 5 mg once daily under close monitoring.
• Administration: Swallow the tablet whole with a glass of water.
• Renal Impairment: Not recommended for use in patients with moderate to severe renal impairment (e.g., creatinine clearance <60 mL/min or estimated glomerular filtration rate <60 mL/min/1.73 m²).
• Precautions: Use with caution in patients with a history of urinary tract infections, genital infections, dehydration, or those on diuretics.
• Pregnancy and Lactation: Not recommended during pregnancy or breastfeeding.